April 24, 2024
Smallpox Treatment Market

Global Smallpox Treatment Is Evolving On The Trends Of Growing Epidemic Outbreaks

The smallpox treatment market consists of drugs and vaccines used for the treatment and prevention of smallpox. Smallpox is a contagious and potentially deadly disease caused by the variola virus. Symptoms of the disease include fever followed by formation of puss-filled lesions on the skin. Several medicines and vaccines are used to either treat patients by curing smallpox or vaccinating individuals to prevent smallpox infections. However, the global eradication of smallpox in 1980 led to cessation of routine smallpox vaccination programs worldwide. The Global Smallpox Treatment Market Size is estimated to be valued at US$ 79.15 Bn in 2024 and is expected to exhibit a CAGR of 27% over the forecast period 2024 to 2030.

Key Takeaways

Key players operating in the Smallpox Treatment market are 42 Degrees Company, ScaldoPack, Heat Food & Drink Ltd, Luxfer Magtech Inc., HeatGen, LLC., LMK Thermosafe, Kemira Inc, Ontech operations Inc., Com-Pac International. Smallpox vaccines produced by key players include ACAM2000 and LC16m8. The threat of smallpox as a bioweapon and growing epidemic outbreaks is fueling demand for smallpox vaccines and drugs globally. Several companies are expanding their presence across international markets like North America, Europe, Asia Pacific, Latin America, and Middle East & Africa to strengthen supply networks and establish global distribution channels.

Market key trends

One of the key trends in the smallpox treatment market is the development of thermostable vaccines. Traditional smallpox vaccines require strict temperature-controlled supply chain from manufacturing to point of vaccination, increasing logistical challenges. New thermostable vaccines under research and development can withstand higher temperatures, reducing cold chain requirements. This makes transportation and storage of vaccines easier in remote and tropical regions prone to epidemic outbreaks. Thermostable vaccines also allow extension of shelf life and facilitate stockpiling of vaccines by governments and international organizations for emergency response. Development of novel thermostable vaccines is expected to boost smallpox preparedness globally.

Porter’s Analysis

Threat of new entrants: The smallpox treatment market has high threat of new entrants due to favorable government policies and funding to develop new treatments for poxviruses. However, setting up manufacturing units requires large capital investments and getting approval for new treatments takes significant time and resources.

Bargaining power of buyers: The bargaining power of buyers in the smallpox treatment market is moderate as the treatments available have few substitutes for treatment of smallpox. However, the buyers can negotiate on price reducing the profits of existing players.

Bargaining power of suppliers: The bargaining power of suppliers is moderate as raw materials for manufacturing smallpox treatments like drugs, vaccines are available from multiple sources globally. Supplier switching costs are also low reducing their bargaining power.

Threat of new substitutes: Threat of new substitutes is low for the smallpox treatment market as there are limited treatment options currently available. Developing new treatments that are more effective takes significant time and resources.

Competitive rivalry: The competitive rivalry in the market is high owing to presence of multiple regional and global players offering similar treatment options. Players compete based on pricing, efficacy and research to develop more effective treatments.

Geographical regions: North America accounts for the major share in terms of value in the global smallpox treatment market currently due to high healthcare spending and presence of leading players.

The Asia Pacific smallpox treatment market is expected to witness the fastest growth during the forecast period led by expanding healthcare infrastructure, large patient pool and growing medical tourism in countries like India and China.

1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it